EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Prehabilitation Targets Associated with the Omission of Adjuvant Chemotherapy After Surgery for Pancreatic Cancer

N C Biesma, E Lemmens, G A Cirkel, M Los, I Q Molenaar, H C van Santvoort, R C Verdonk, L A Daamen, P G Noordzij

Journal of Gastrointestinal Cancer · 2025

DOI: 10.1007/s12029-025-01357-y ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Gastrointestinal Cancer, 2025. Verfasst von N C Biesma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Regional Academic Cancer Center Utrecht, University Medical Center Utrecht Cancer Center & St. Antonius Hospital Nieuwegein, N…. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Pancreaticoduodenectomy, Postoperative Complications, Preoperative Exercise. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Curative treatment for pancreatic cancer relies on surgical resection combined with systemic chemotherapy, administered either before (neoadjuvant) or after (adjuvant) surgery. However, a considerable proportion of patients undergoing upfront resection fail to receive adjuvant chemotherapy, which negatively impacts survival. Identifying modifiable preoperative factors contributing to this omission could improve postoperative outcomes. This study investigated potential prehabilitation targets associated with the omission of adjuvant chemotherapy following pancreatic cancer surgery. METHODS: We conducted a post-hoc analysis of a prospective observational cohort including all patients who underwent pancreaticoduodenectomy at the Regional Academic Cancer Centre Utrecht between 2016 and 2022. The primary outcome was omission of adjuvant chemotherapy. Associations between prehabilitation-related factors-smoking, alcohol use, nutritional status, anemia, mobility, muscle strength, mental stress, and exocrine pancreatic insufficiency-were assessed using logistic regression. As a secondary analysis, we examined the relationship between these factors and major postoperative complications, a known determinant of chemotherapy omission. RESULTS: In total, 214 patients were included of which 115 patients (54%) were male with a median age of 70 years (± 7 years). A total of 70/214 patients (33%) did not start with adjuvant chemotherapy. Only smoking was independently associated with omitting chemotherapy (adjusted odds ratio (aOR) 2.98, 95% confidence interval (CI) 1.25-7.13, P < 0.01). Patients who suffered from major postoperative complications were less likely to receive adjuvant chemotherapy (aOR 2.36, 95%CI 1.07-5.18, P = 0.03). Again, only smoking was associated with a major postoperative complication (aOR 2.27, 95% CI 1.08-4.76). CONCLUSION: Smoking is a modifiable prehabilitation target linked to both omission of adjuvant chemotherapy and increased risk of major postoperative complications following pancreatic surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsPancreaticoduodenectomyPostoperative ComplicationsPreoperative ExerciseHumansMaleChemotherapy, AdjuvantFemaleAgedProspective StudiesMiddle AgedSmoking

Autor:innen und Institutionen

  • Department of Surgery, Regional Academic Cancer Center Utrecht, University Medical Center Utrecht Cancer Center & St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands. N.C.Biesma-2@umcutrecht.nl.
  • Department of Surgery, Regional Academic Cancer Center Utrecht, University Medical Center Utrecht Cancer Center & St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.
  • Department of Medical Oncology, St. Antonius Hospital Nieuwegein, Nieuwegein, The Netherlands.
  • Department of Gastroenterology and Hepatology, St Antonius Hospital, Nieuwegein, The Netherlands.
  • Department of Radiation Oncology, University Medical Center Utrecht Cancer Center, Utrecht, The Netherlands.
  • Department of Anesthesiology, Intensive Care and Pain Medicine, St Antonius Hospital, Nieuwegein, Utrecht, 3508 GA, The Netherlands. p.noordzij@antoniusziekenhuis.nl.

Zitieren

APA

Biesma, N. C., Lemmens, E., Cirkel, G. A., Los, M., Molenaar, I. Q., van Santvoort, H. C., Verdonk, R. C., Daamen, L. A., & Noordzij, P. G. (2025). Prehabilitation Targets Associated with the Omission of Adjuvant Chemotherapy After Surgery for Pancreatic Cancer. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-025-01357-y

Vancouver

Biesma NC, Lemmens E, Cirkel GA, Los M, Molenaar IQ, van Santvoort HC, et al. Prehabilitation Targets Associated with the Omission of Adjuvant Chemotherapy After Surgery for Pancreatic Cancer. Journal of Gastrointestinal Cancer. 2025. doi:10.1007/s12029-025-01357-y

BibTeX
@article{Biesma2025,
  author = {Biesma, N C and Lemmens, E and Cirkel, G A and Los, M and Molenaar, I Q and van Santvoort, H C and Verdonk, R C and Daamen, L A and Noordzij, P G},
  title = {Prehabilitation Targets Associated with the Omission of Adjuvant Chemotherapy After Surgery for Pancreatic Cancer},
  journal = {Journal of Gastrointestinal Cancer},
  year = {2025},
  doi = {10.1007/s12029-025-01357-y}
}
Kostenlos starten →